On March 13, 2024, Mycenax Biotech Inc. cancelled the transaction. The transaction has been approved by the shareholders of the company.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
42.5 TWD | -3.95% | -7.81% | +19.05% |
14/03 | Mycenax Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
13/03 | Mycenax Biotech Inc. Announces the Appointment of Li-Ju Yeh as Corporate Governance Officer | CI |
1st Jan change | Capi. | |
---|---|---|
+19.05% | 281M | |
+7.52% | 111B | |
+11.38% | 106B | |
-12.64% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.58% | 16.81B | |
+37.41% | 12.54B | |
-23.95% | 8.09B |
- Stock Market
- Equities
- 4726 Stock
- News Mycenax Biotech Inc.
- Mycenax Biotech Inc. cancelled the transaction announced on March 13, 2023